ChitogenX Inc. (CHNXF)
OTCMKTS · Delayed Price · Currency is USD
0.0076
+0.0065 (590.91%)
At close: Dec 17, 2025
ChitogenX Market Cap
ChitogenX has a market cap or net worth of $303.81 thousand as of February 12, 2026. Its market cap has decreased by -96.04% in one year.
Market Cap
303.81K
Enterprise Value
3.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 10, 2017, ChitogenX's market cap has decreased from 14.77M to 303.81K, a decrease of -97.94%. That is a compound annual growth rate of -39.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2025 | 303.81K | -64.94% |
| Dec 30, 2024 | 866.52K | -78.82% |
| Dec 29, 2023 | 4.09M | -58.27% |
| Dec 30, 2022 | 9.80M | 7.56% |
| Dec 31, 2021 | 9.12M | -48.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 515.05K |
| Avenue Therapeutics | 494.20K |
| Hepion Pharmaceuticals | 429.95K |
| Actavia Life Sciences | 385.91K |
| Windtree Therapeutics | 371.98K |
| THC Farmaceuticals | 362.63K |
| Oncology Pharma | 334.65K |
| Ocean Biomedical | 325.31K |